Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 700

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Milk-derived bioactive peptides: From science to applications

Open access
Korhonen, Hannu·2009·Journal of Functional Foods

Abstract

Abstract Milk proteins have received increasing attention as potential ingredients of health-promoting functional foods targeted at diet-related chronic diseases, such as cardiovascular disease, diabetes type two and obesity. To this end, growing interest has been focused on physiologically active peptides derived from milk proteins. These peptides are inactive within the sequence of the parent protein molecule and can be liberated by gastrointestinal digestion of milk, fermentation of milk with proteolytic starter cultures or hydrolysis by proteolytic enzymes. Milk protein-derived peptides have been shown under in vitro and in vivo conditions to exert a number of activities affecting the digestive, endocrine, cardiovascular, immune and nervous systems. A great variety of naturally formed bioactive peptides have been found in fermented dairy products, such as yoghurt, sour milk and cheese. Recently, industrial-scale technologies suitable for the industrial production of bioactive milk peptides have been developed. In addition, a few commercial food products supplemented with milk protein-derived bioactive peptides have been launched on limited markets. Some of these products carry clinically documented benefits, in particular for reduction of mild hypertension. The multifunctional properties of milk peptides appear to offer considerable potential for the development of many similar products in the near future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jff.2009.01.007

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 7 references

Research works printed but not linked: 93

  1. Aihara, 2005, Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension, Journal of American College of Nutrition, 4, 257, 10.1080/07315724.2005.10719473 · DOI
  2. Ashar, 2004, Fermented milk containing ACE-inhibitory peptides reduces blood pressure in middle aged hypertensive subjects, Milchwissenschaft, 59, 363
  3. Ardö, 2007, Identification of large phosphopeptides from β-casein that characteristically accumulate during ripening of the semi-hard cheese Herrgård, International Dairy Journal, 17, 513, 10.1016/j.idairyj.2006.06.027 · DOI
  4. Bütikofer, 2007, Quantification of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in hard, semi-hard and soft cheeses, International Dairy Journal, 17, 968, 10.1016/j.idairyj.2006.11.003 · DOI
  5. Chen, 2007, Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation, International Dairy Journal, 17, 641, 10.1016/j.idairyj.2006.07.004 · DOI
  6. Chobert, 2005, Angiotensin I-converting-enzyme (ACE) inhibitory activity of tryptic peptides of ovine β-lactoglobulin and of milk yoghurts obtained by using different starters, Lait, 85, 141, 10.1051/lait:2005005 · DOI
  7. deCosta, 2007, Effect of heat and enzymatic treatment on the antihypertensive activity of whey protein hydrolysates, International Dairy Journal, 17, 632, 10.1016/j.idairyj.2006.09.003 · DOI
  8. Donkor, 2007, Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of growth and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk, Lait, 86, 21, 10.1051/lait:2006023 · DOI
  9. Erdman, 2008, The possible role of food-derived bioactive peptides in reducing the risk of cardiovascular disease, Journal of Nutritional Biochemistry, 19, 643, 10.1016/j.jnutbio.2007.11.010 · DOI · Paper page
  10. Engberink, 2008, Lactotripeptides show no effect on human blood pressure: Results from a double-blind randomized controlled trial, Hypertension, 51, 399, 10.1161/HYPERTENSIONAHA.107.098988 · DOI
  11. Ferreira, 2007, Preparation of ingredients containing an ACE-inhibitory peptide by tryptic hydrolysis of whey protein concentrates, International Dairy Journal, 17, 481, 10.1016/j.idairyj.2006.06.023 · DOI
  12. FitzGerald, 2003, Milk protein hydrolysates and bioactive peptides, Vol. 1, 675
  13. FitzGerald, 2004, Hypotensive peptides from milk proteins, Journal of Nutrition, 134, 980S, 10.1093/jn/134.4.980S · DOI · Paper page
  14. Foltz, 2007, Angiotensin converting enzyme inhibitory peptides from a lactotripeptide – Enriched milk beverage are absorbed intact into the circulation, Journal of Nutrition, 137, 953, 10.1093/jn/137.4.953 · DOI · Paper page
  15. Fuglsang, 2003, Lactic acid bacteria: Inhibition of angiotensin converting enzyme in vitro and in vivo, Antonie van Leeuwenhoek, 83, 27, 10.1023/A:1022993905778 · DOI
  16. Gauthier, 2006, Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins, International Dairy Journal, 16, 1315, 10.1016/j.idairyj.2006.06.014 · DOI · Paper page
  17. Gobbetti, 2004, Angiotensin I-converting-enzyme-inhibitory and antimicrobial bioactive peptides, International Journal of Dairy Technology, 57, 172, 10.1111/j.1471-0307.2004.00139.x · DOI · Paper page
  18. Gobbetti, 2002, Latent bioactive peptides in milk proteins: Proteolytic activation and significance in dairy processing, Critical Reviews in Food Science and Nutrition, 42, 223, 10.1080/10408690290825538 · DOI · Paper page
  19. Gomez-Ruiz, 2002, Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures, International Dairy Journal, 12, 697, 10.1016/S0958-6946(02)00059-6 · DOI
  20. Haque, 2008, Antihypertensive and antimicrobial bioactive peptides from milk proteins, European Food Research and Technology, 227, 7, 10.1007/s00217-007-0689-6 · DOI
  21. Hata, 1996, A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects, American Journal of Clinical Nutrition, 64, 767, 10.1093/ajcn/64.5.767 · DOI
  22. Hernández-Ledesma, 2004, Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion, Journal of Agricultural and Food Chemistry, 52, 1504, 10.1021/jf034997b · DOI
  23. Hernández-Ledesma, 2004, Release of angiotensin converting enzyme-inhibitory peptides by simulated gastrointestinal digestion of infant formulas, International Dairy Journal, 14, 889, 10.1016/j.idairyj.2004.02.011 · DOI
  24. Hernández-Ledesma, 2007, Identification of bioactive peptides after digestion of human milk and infant formula with pepsin and pancreatin, International Dairy Journal, 17, 42, 10.1016/j.idairyj.2005.12.012 · DOI · Paper page
  25. Hirota, 2007, Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme, Hypertension Research, 30, 489, 10.1291/hypres.30.489 · DOI
  26. Jauhiainen, 2007, Milk peptides and blood pressure, Journal of Nutrition, 137, 825S, 10.1093/jn/137.3.825S · DOI
  27. Jauhiainen, 2005, Lactobacillus helveticus fermented milk reduces blood pressure in 24-h ambulatory blood pressure measurement, American Journal of Hypertension, 18, 1600, 10.1016/j.amjhyper.2005.06.006 · DOI
  28. Jauhiainen, 2007, Oral absorption, tissue distribution and excretion of a radiolabelled analog of a milk-derived antihypertensive peptide, Ile-Pro-Pro, in rats, International Dairy Journal, 17, 1216, 10.1016/j.idairyj.2007.02.004 · DOI
  29. Jauhiainen, 2007, Lactobacillus helveticus fermented milk reduces arterial stiffness in hypertensive subjects, International Dairy Journal, 17, 1209, 10.1016/j.idairyj.2007.03.002 · DOI
  30. Kilara, 2003, Peptides from milk proteins and their properties, Critical Reviews in Food Science and Nutrition, 43, 607, 10.1080/10408690390251138 · DOI
  31. Kilpi, 2007, Angiotensin I-converting enzyme inhibitory activity in milk fermented by wild-type and peptidase-deletion derivatives of Lactobacillus helveticus CNRZ32, International Dairy Journal, 17, 976, 10.1016/j.idairyj.2006.12.001 · DOI
  32. Kim, 1999, Novel angiotensin-I-converting enzyme inhibitory peptides derived from recombinant human αs1-casein expressed in Escherichia coli, Journal of Dairy Research, 66, 431, 10.1017/S0022029999003556 · DOI
  33. Kitts, 2003, Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery, Current Pharmaceutical Design, 9, 1309, 10.2174/1381612033454883 · DOI · Paper page
  34. Korhonen, 2002, Technology options for new nutritional concepts, International Journal of Dairy Technology, 55, 79, 10.1046/j.1471-0307.2002.00050.x · DOI
  35. Korhonen, 2003, Food-derived bioactive peptides – Opportunities for designing future foods, Current Pharmaceutical Design, 9, 1297, 10.2174/1381612033454892 · DOI
  36. Korhonen, 2006, Bioactive peptides: Production and functionality, International Dairy Journal, 16, 945, 10.1016/j.idairyj.2005.10.012 · DOI · Paper page
  37. Korhonen, 2007, Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum, Current Pharmaceutical Design, 13, 829, 10.2174/138161207780363112 · DOI
  38. Lee, 2007, Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension, European Journal of Nutrition, 46, 21, 10.1007/s00394-006-0625-8 · DOI
  39. Li, 2004, Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects, Nutrition Research, 24, 469, 10.1016/S0271-5317(04)00058-2 · DOI
  40. López-Fandino, 2006, Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity, International Dairy Journal, 16, 1277, 10.1016/j.idairyj.2006.06.004 · DOI
  41. López-Expósito, 2007, Casein hydrolysates as a source of antimicrobial, antioxydant and antihypertensive peptides, Lait, 87, 241, 10.1051/lait:2007019 · DOI
  42. López-Expósito, 2006, Antibacterial activity of peptides and folding variants from milk proteins, International Dairy Journal, 16, 1294, 10.1016/j.idairyj.2006.06.002 · DOI
  43. López-Expósito, 2008, Protective effect of milk peptides: Antibacterial and antitumor properties, Vol. 606, 271
  44. Lorenzen, 2005, Influence of trypsin action in yoghurt milk on the release of caseinophosphopeptide-rich fractions and physical properties of the fermented products, International Journal of Dairy Technology, 58, 119, 10.1111/j.1471-0307.2005.00195.x · DOI
  45. Maes, 2004, Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells, Regulatory Peptides, 118, 105, 10.1016/j.regpep.2003.11.005 · DOI
  46. Manso, 2004, κ-Casein macropeptides from cheese whey: Physicochemical, biological, nutritional, and technological features for possible uses, Food Reviews International, 20, 329, 10.1081/FRI-200033456 · DOI
  47. Masuda, 1996, Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats, Journal of Nutrition, 126, 3063, 10.1093/jn/126.12.3063 · DOI · Paper page
  48. McDonagh, 1998, Production of caseinophosphopeptides (CPPs) from sodium caseinate using a range of commercial protease preparations, International Dairy Journal, 8, 39, 10.1016/S0958-6946(98)00019-3 · DOI
  49. Meisel, 2005, Biochemical properties of peptides encrypted in bovine milk proteins, Current Medicinal Chemistry, 12, 1905, 10.2174/0929867054546618 · DOI · Paper page
  50. Meisel, 1997, ACE-inhibitory activities in milk products, Milchwissenschaft, 52, 307
  51. Meisel, 2006, ACE inhibitory peptides, Vol. 4, 269
  52. Mizuno, 2005, Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high normal blood pressure and mild hypertension, British Journal of Nutrition, 94, 84, 10.1079/BJN20051422 · DOI
  53. Mizushima, 2004, Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men, American Journal of Hypertension, 17, 701, 10.1016/j.amjhyper.2004.03.674 · DOI
  54. Muehlenkamp, 1996, β-Casomorphins: Analysis in cheese and susceptibility to proteolytic enzymes from Lactococcus lactis ssp. cremoris, Journal of Dairy Science, 79, 20, 10.3168/jds.S0022-0302(96)76329-4 · DOI
  55. Mullally, 1997, Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine β-lactoglobulin, FEBS Letters, 402, 99, 10.1016/S0014-5793(96)01503-7 · DOI · Paper page
  56. Murray, 2007, Angiotensin converting enzyme inhibitory peptides derived from food proteins: Biochemistry, bioactivity and production, Current Pharmaceutical Design, 13, 773, 10.2174/138161207780363068 · DOI · Paper page
  57. Möller, 2008, Bioactive peptides and proteins from foods: Indication for health effects, European Journal of Nutrition, 47, 171, 10.1007/s00394-008-0710-2 · DOI · Paper page
  58. Nakamura, 1995, Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme, Journal of Dairy Science, 78, 1253, 10.3168/jds.S0022-0302(95)76745-5 · DOI · Paper page
  59. O‘Donnell, 2004, Milk proteomics, International Dairy Journal, 14, 1013, 10.1016/j.idairyj.2004.04.004 · DOI
  60. Ong, 2007, Angiotensin converting enzyme-inhibitory activity in Cheddar cheeses made with the addition of probiotic Lactobacillus casei sp., Lait, 87, 149, 10.1051/lait:2007004 · DOI
  61. Otte, 2007, Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates: Effect of substrate, enzyme and time of hydrolysis, International Dairy Journal, 17, 488, 10.1016/j.idairyj.2006.05.011 · DOI
  62. Quiros, 2005, Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir, Journal of Dairy Science, 88, 3480, 10.3168/jds.S0022-0302(05)73032-0 · DOI · Paper page
  63. Quiros, 2007, Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis, International Dairy Journal, 17, 33, 10.1016/j.idairyj.2005.12.011 · DOI
  64. Pan, 2004, Antihypertensive peptides from skimmed milk hydrolysate digested by cell-free extract of Lactobacillus helveticus JCM1004, Food Chemistry, 91, 123, 10.1016/j.foodchem.2004.05.055 · DOI
  65. Parrot, 2003, In vitro study on digestion of peptides in Emmental cheese: Analytical evaluation and influence on angiotensin I converting enzyme inhibitory peptides, Nahrung, 47, 87, 10.1002/food.200390032 · DOI
  66. Pihlanto, 2006, Antioxidative peptides derived from milk proteins, International Dairy Journal, 16, 1306, 10.1016/j.idairyj.2006.06.005 · DOI
  67. Pihlanto, 2003, Bioactive peptides and proteins, Vol. 47, 175
  68. Pihlanto-Leppälä, 2000, Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides, Journal of Dairy Research, 67, 53, 10.1017/S0022029999003982 · DOI · Paper page
  69. Pihlanto-Leppälä, 1998, Angiotensin I-converting enzyme inhibitory peptides derived from bovine milk proteins, International Dairy Journal, 8, 325, 10.1016/S0958-6946(98)00048-X · DOI · Paper page
  70. Pouliot, 2006, Membrane-based fractionation and purification strategies for bioactive peptides, Vol. 4, 639
  71. Reynolds, 2003, Dairy components in oral health, Australian Journal of Dairy Technology, 58, 79
  72. Rokka, 1997, Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT-milk, Milchwissenschaft, 52, 675
  73. Roudot-Algaron, 1994, Phosphopeptides from Comté cheese: Nature and origin, Journal of Food Science, 59, 544, 10.1111/j.1365-2621.1994.tb05558.x · DOI
  74. Roufik, 2006, In vitro digestibility of bioactive peptides derived from bovine β-lactoglobulin, International Dairy Journal, 16, 294, 10.1016/j.idairyj.2005.03.010 · DOI
  75. Ryhänen, 2001, A new type of ripened: Low-fat cheese with bioactive properties, International Dairy Journal, 11, 441, 10.1016/S0958-6946(01)00079-6 · DOI
  76. Sabikhi, 2001, Qualitative and quantitative analysis of β-casomorphins in Edam cheese, Milchwissenschaft, 56, 198
  77. Saito, 2000, Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese, Journal of Dairy Science, 83, 1434, 10.3168/jds.S0022-0302(00)75013-2 · DOI · Paper page
  78. Saito, 2008, Antihypertensive peptides derived from bovine casein and whey proteins, Vol. 606, 295
  79. Sano, 2005, Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension, Journal of Medicinal Food, 8, 423, 10.1089/jmf.2005.8.423 · DOI
  80. Seppo, 2003, A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects, American Journal of Clinical Nutrition, 77, 326, 10.1093/ajcn/77.2.326 · DOI · Paper page
  81. Seppo, 2002, The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension – A pilot study on humans, Milchwissenschaft, 57, 124
  82. Silva, 2005, Caseins as source of bioactive peptides, International Dairy Journal, 15, 1, 10.1016/j.idairyj.2004.04.009 · DOI · Paper page
  83. Singh, 1997, Isolation and identification of further peptides in the diafiltration retentate of the water-soluble fraction of Cheddar cheese, Journal of Dairy Research, 64, 433, 10.1017/S0022029997002227 · DOI · Paper page
  84. Sipola, 2002, Effect of long-term intake of milk products on blood pressure in hypertensive rats, Journal of Dairy Research, 69, 103, 10.1017/S002202990100526X · DOI
  85. Smacchi, 1998, Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria: Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme, Enzyme Microbiology and Technology, 22, 687, 10.1016/S0141-0229(97)00261-5 · DOI
  86. Takano, 2002, Anti-hypertensive activity of fermented dairy products containing biogenic peptides, Antonie van Leeuwenhoek, 82, 333, 10.1023/A:1020600119907 · DOI
  87. Teschemacher, 2003, Opioid receptor ligands derived from food proteins, Current Pharmaceutical Design, 9, 1331, 10.2174/1381612033454856 · DOI
  88. Townsend, 2004, A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension, American Journal of Hypertension, 17, 1056, 10.1016/j.amjhyper.2004.06.018 · DOI
  89. Tuomilehto, 2004, Effect of ingesting sour milk fermented by Lactobacillus helveticus bacteria on blood pressure in subjects with mild hypertension, Journal of Human Hypertension, 18, 795, 10.1038/sj.jhh.1001745 · DOI
  90. Vermeirssen, 2004, Bioavailability of angiotensin I-converting enzyme inhibitory peptides, British Journal of Nutrition, 92, 357, 10.1079/BJN20041189 · DOI · Paper page
  91. Virtanen, 2006, Development of antioxidant activity in milk whey during fermentation with lactic acid bacteria, Journal of Applied Microbiology, 102, 106, 10.1111/j.1365-2672.2006.03072.x · DOI · Paper page
  92. Zimecki, 2007, Milk-derived proteins and peptides of potential therapeutic and nutritive value, Journal of Experimental Therapy and Oncology, 6, 89
  93. Yamamoto, 2003, Biogenic peptides and their potential use, Current Pharmaceutical Design, 9, 1345, 10.2174/1381612033454801 · DOI

Cited by

See all 700

Metadata

Authors
Korhonen, H.
Venue
Journal of Functional Foods
Publisher
Elsevier BV
Published
2009-04
Volume
1
Issue
2
Pages
177-187
ISSN
1756-4646 (ISSN-L)
OpenAlex
W2028989327
Cited by
700
References
7
FWCI
12.12
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Milk-derived bioactive peptides: From science to applications. https://app.cochat.ai/papers/10.1016/j.jff.2009.01.007
The paper
Korhonen, H. (2009). Milk-derived bioactive peptides: From science to applications. Journal of Functional Foods. https://doi.org/10.1016/j.jff.2009.01.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.